Chapter/Section Purchase

1 Study Coverage
1.1 Hemophilia A Drug Product Introduction
1.2 Market by Type
1.2.1 Global Hemophilia A Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ATXF-8117
1.2.3 BAY-1093884
1.2.4 BIVV-001
1.2.5 BS-027125
1.2.6 Concizumab
1.2.7 CSL-689
1.2.8 Others
1.3 Market by Application
1.3.1 Global Hemophilia A Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemophilia A Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Hemophilia A Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Hemophilia A Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hemophilia A Drug Sales by Region
2.4.1 Global Hemophilia A Drug Sales by Region (2017-2022)
2.4.2 Global Sales Hemophilia A Drug by Region (2023-2028)
2.5 Global Hemophilia A Drug Revenue by Region
2.5.1 Global Hemophilia A Drug Revenue by Region (2017-2022)
2.5.2 Global Hemophilia A Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hemophilia A Drug Sales by Manufacturers
3.1.1 Global Top Hemophilia A Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Hemophilia A Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hemophilia A Drug in 2021
3.2 Global Hemophilia A Drug Revenue by Manufacturers
3.2.1 Global Hemophilia A Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Hemophilia A Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hemophilia A Drug Revenue in 2021
3.3 Global Hemophilia A Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hemophilia A Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hemophilia A Drug Sales by Type
4.1.1 Global Hemophilia A Drug Historical Sales by Type (2017-2022)
4.1.2 Global Hemophilia A Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Hemophilia A Drug Sales Market Share by Type (2017-2028)
4.2 Global Hemophilia A Drug Revenue by Type
4.2.1 Global Hemophilia A Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Hemophilia A Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hemophilia A Drug Revenue Market Share by Type (2017-2028)
4.3 Global Hemophilia A Drug Price by Type
4.3.1 Global Hemophilia A Drug Price by Type (2017-2022)
4.3.2 Global Hemophilia A Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hemophilia A Drug Sales by Application
5.1.1 Global Hemophilia A Drug Historical Sales by Application (2017-2022)
5.1.2 Global Hemophilia A Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Hemophilia A Drug Sales Market Share by Application (2017-2028)
5.2 Global Hemophilia A Drug Revenue by Application
5.2.1 Global Hemophilia A Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Hemophilia A Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hemophilia A Drug Revenue Market Share by Application (2017-2028)
5.3 Global Hemophilia A Drug Price by Application
5.3.1 Global Hemophilia A Drug Price by Application (2017-2022)
5.3.2 Global Hemophilia A Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hemophilia A Drug Market Size by Type
6.1.1 North America Hemophilia A Drug Sales by Type (2017-2028)
6.1.2 North America Hemophilia A Drug Revenue by Type (2017-2028)
6.2 North America Hemophilia A Drug Market Size by Application
6.2.1 North America Hemophilia A Drug Sales by Application (2017-2028)
6.2.2 North America Hemophilia A Drug Revenue by Application (2017-2028)
6.3 North America Hemophilia A Drug Market Size by Country
6.3.1 North America Hemophilia A Drug Sales by Country (2017-2028)
6.3.2 North America Hemophilia A Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hemophilia A Drug Market Size by Type
7.1.1 Europe Hemophilia A Drug Sales by Type (2017-2028)
7.1.2 Europe Hemophilia A Drug Revenue by Type (2017-2028)
7.2 Europe Hemophilia A Drug Market Size by Application
7.2.1 Europe Hemophilia A Drug Sales by Application (2017-2028)
7.2.2 Europe Hemophilia A Drug Revenue by Application (2017-2028)
7.3 Europe Hemophilia A Drug Market Size by Country
7.3.1 Europe Hemophilia A Drug Sales by Country (2017-2028)
7.3.2 Europe Hemophilia A Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hemophilia A Drug Market Size by Type
8.1.1 Asia Pacific Hemophilia A Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Hemophilia A Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Hemophilia A Drug Market Size by Application
8.2.1 Asia Pacific Hemophilia A Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Hemophilia A Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Hemophilia A Drug Market Size by Region
8.3.1 Asia Pacific Hemophilia A Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Hemophilia A Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hemophilia A Drug Market Size by Type
9.1.1 Latin America Hemophilia A Drug Sales by Type (2017-2028)
9.1.2 Latin America Hemophilia A Drug Revenue by Type (2017-2028)
9.2 Latin America Hemophilia A Drug Market Size by Application
9.2.1 Latin America Hemophilia A Drug Sales by Application (2017-2028)
9.2.2 Latin America Hemophilia A Drug Revenue by Application (2017-2028)
9.3 Latin America Hemophilia A Drug Market Size by Country
9.3.1 Latin America Hemophilia A Drug Sales by Country (2017-2028)
9.3.2 Latin America Hemophilia A Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hemophilia A Drug Market Size by Type
10.1.1 Middle East and Africa Hemophilia A Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hemophilia A Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Hemophilia A Drug Market Size by Application
10.2.1 Middle East and Africa Hemophilia A Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hemophilia A Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Hemophilia A Drug Market Size by Country
10.3.1 Middle East and Africa Hemophilia A Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hemophilia A Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Overview
11.1.3 Bayer AG Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer AG Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer AG Recent Developments
11.2 BioMarin Pharmaceutical Inc
11.2.1 BioMarin Pharmaceutical Inc Corporation Information
11.2.2 BioMarin Pharmaceutical Inc Overview
11.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 BioMarin Pharmaceutical Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BioMarin Pharmaceutical Inc Recent Developments
11.3 Bioverativ Inc
11.3.1 Bioverativ Inc Corporation Information
11.3.2 Bioverativ Inc Overview
11.3.3 Bioverativ Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bioverativ Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bioverativ Inc Recent Developments
11.4 Catalyst Biosciences Inc
11.4.1 Catalyst Biosciences Inc Corporation Information
11.4.2 Catalyst Biosciences Inc Overview
11.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Catalyst Biosciences Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Catalyst Biosciences Inc Recent Developments
11.5 Chugai Pharmaceutical Co Ltd
11.5.1 Chugai Pharmaceutical Co Ltd Corporation Information
11.5.2 Chugai Pharmaceutical Co Ltd Overview
11.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chugai Pharmaceutical Co Ltd Recent Developments
11.6 CSL Ltd
11.6.1 CSL Ltd Corporation Information
11.6.2 CSL Ltd Overview
11.6.3 CSL Ltd Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CSL Ltd Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CSL Ltd Recent Developments
11.7 DBV Technologies SA
11.7.1 DBV Technologies SA Corporation Information
11.7.2 DBV Technologies SA Overview
11.7.3 DBV Technologies SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 DBV Technologies SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 DBV Technologies SA Recent Developments
11.8 Dimension Therapeutics Inc
11.8.1 Dimension Therapeutics Inc Corporation Information
11.8.2 Dimension Therapeutics Inc Overview
11.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dimension Therapeutics Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dimension Therapeutics Inc Recent Developments
11.9 EpiVax Inc
11.9.1 EpiVax Inc Corporation Information
11.9.2 EpiVax Inc Overview
11.9.3 EpiVax Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 EpiVax Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 EpiVax Inc Recent Developments
11.10 Expression Therapeutics LLC
11.10.1 Expression Therapeutics LLC Corporation Information
11.10.2 Expression Therapeutics LLC Overview
11.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Expression Therapeutics LLC Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Expression Therapeutics LLC Recent Developments
11.11 Green Cross Corp
11.11.1 Green Cross Corp Corporation Information
11.11.2 Green Cross Corp Overview
11.11.3 Green Cross Corp Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Green Cross Corp Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Green Cross Corp Recent Developments
11.12 Idogen AB
11.12.1 Idogen AB Corporation Information
11.12.2 Idogen AB Overview
11.12.3 Idogen AB Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Idogen AB Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Idogen AB Recent Developments
11.13 Immusoft Corp
11.13.1 Immusoft Corp Corporation Information
11.13.2 Immusoft Corp Overview
11.13.3 Immusoft Corp Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Immusoft Corp Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Immusoft Corp Recent Developments
11.14 LFB SA
11.14.1 LFB SA Corporation Information
11.14.2 LFB SA Overview
11.14.3 LFB SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 LFB SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 LFB SA Recent Developments
11.15 mAbxience SA
11.15.1 mAbxience SA Corporation Information
11.15.2 mAbxience SA Overview
11.15.3 mAbxience SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 mAbxience SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 mAbxience SA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hemophilia A Drug Industry Chain Analysis
12.2 Hemophilia A Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hemophilia A Drug Production Mode & Process
12.4 Hemophilia A Drug Sales and Marketing
12.4.1 Hemophilia A Drug Sales Channels
12.4.2 Hemophilia A Drug Distributors
12.5 Hemophilia A Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hemophilia A Drug Industry Trends
13.2 Hemophilia A Drug Market Drivers
13.3 Hemophilia A Drug Market Challenges
13.4 Hemophilia A Drug Market Restraints
14 Key Findings in The Global Hemophilia A Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer